Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
项目新闻 I Adcentrx Therapeutics宣布，FDA批准其靶向STEAP1的潜在首创ADC产品ADRX-0405临床试验申请
Adcentrx Therapeutics Reports the US FDA’s IND Clearance of ADRX-0405 ...
Adcentrx Therapeutics - 2025 Company Profile, Team, Funding ...
News - Adcentrx Therapeutics
Adcentrx Therapeutics announces FDA clearance of Investigational New ...
Adcentrx Therapeutics申请Nectin-4 ADC IND 已获 FDA 批准医药新闻-ByDrug-一站式医药资源共享 ...
Adcentrx Therapeutics
海外 New Things | Adcentrx Therapeutics获1300万美元A轮融资，研发治疗癌症的ADC药物-36氪
Adcentrx Therapeutics - F-Prime Capital
Adcentrx Therapeutics | The Org
Adcentrx Therapeutics完成3800万美元 A+轮融资医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Pipeline - Adcentrx Therapeutics
Careers - Adcentrx Therapeutics
About - Adcentrx Therapeutics
Our Science - Adcentrx Therapeutics
Adcentrx Therapeutics Announces FDA Clearance of Investigational New ...
Adcentrx receives NMPA approval for solid tumour therapy trial
Our investment in Adcentrx Therapeutics | Eight Roads
FDA Grants Orphan Drug Designation to Adcentrx Therapeutics’ ADRX-0405 ...
Adcentrx Therapeutics Gains China's NMPA IND Approval for ADRX-0706, a ...
Management Team - Adcentrx Therapeutics
Contact - Adcentrx Therapeutics
Adcentrx Therapeutics Receives Fast Track Status for Advanced Cervical ...
Adcentrx Therapeutics starts Phase 1a/b trials of ADRX-0706, a new ADC ...
Adcentrx Therapeutics 2026 Company Profile: Valuation, Funding ...
Adcentrx 宣布 A+ 轮融资增加至5100万美元 | 每经网
AbbVie sued Adcentrx Therapeutics for trade secret breach | Photon ...
Adcentrx to Present Early Nectin-4 ADC Data at 2024 AACR Convention
Adcentrx Therapeutics to Present First Clinical Data for ADC Candidate ...
Adcentrx Therapeutics宣布美国FDA已批准其用于治疗晚期实体肿瘤,针对Nectin-4的新型ADC药物ADRX-0706的 ...
Adcentrx Therapeutics Inc. - Page 1 | BioWorld
Adcentrx 宣布 FDA 批准其靶向 STEAP1 的潜在首创 ADC 产品 ADRX-0405 临床试验申请 丨光源伙伴_腾讯新闻
U.S. FDA Grants Orphan Drug Designation to Adcentrx Therapeutics’ ADRX ...
Adcentrx 宣布 Nectin-4 ADC ADRX-0706 完成 1b 临床扩展阶段首例受试者给药丨光源伙伴_腾讯新闻
#orphandrugdesignation #oncology #fda | Adcentrx Therapeutics
With the completion of their Series A funding round, having raised $38 ...
Adcentrx宣布A+轮融资增加至5100万美元-投资家网
德烽药业Adcentrx宣布A+轮融资增加至5100万美元 - 张通社
February 15 2022
“Adcentrx Therapeutics”完成3800万美元 A＋轮融资，光源资本担任财务顾问｜光源交易_腾讯新闻
FDA grants Fast Track to ADRX-0706 for advanced cervical cancer ...
Adcentrx’s Nectin-4 ADC, ADRX-0706, Earns FDA Fast Track for Cervical ...
Regulatory - Optimal Dose
新一代ADC药物研发企业Adcentrx Therapeutics完成3800万美元 A+轮融资 - 动点科技
ADVENTRX Pharmaceuticals – Acquired by Mast Therapeutics (AMEX) in 2007 ...
Eluciderm, Inc. Announces U.S. FDA Clearance of IND Application for ...
#aacr2025 #adcs #cancerresearch #biotech #oncologyinnovations ...
项目新闻 I 三一创新投资被投企业Adcentrx 宣布 A+ 轮融资增加至5100万美元
斯道发布 | 新一代ADC药物研发企业Adcentrx Therapeutics完成3800万美元A+轮融资，斯道资本领投医药新闻 ...
「Adcentrx」宣布其靶向 STEAP1 的潜在首创 ADC 产品 ADRX-0405 完成临床首例受试者给药丨光源伙伴_腾讯新闻
Adventrx Pharmaceuticals - Canaccord Genuity
Adventrx gets FDA review date for new formulation of cancer drug – San ...
Adcentrx治疗公司宣布在ADRX-0405的1a/b期研究中注射首位患者，这是一种针对STEAP1的潜在首款抗体药物偶联物，用于治疗晚期实体瘤。
ADVENTRX | SMG Securities
Success Stories | adventrx
Clients – Clear Financial Solutions Inc.
Drug Development Stock, ADVENTRX Pharmaceuticals, Inc. (ANX-NYSE AMEX)
(PERFORMANCE GRAPH)
ADVENTRX PHARMACEUTICALS Refining therapies for life
Adventrx Pharmaceuticals: Its Orphan Drug Could Attract Partners ...
Adventrx to Acquire SynthRx in Staged Stock-Base Deal for Phase III ...
Adventrx Pharmaceuticals | Investing.com
11
ADVENTRX CEO Brian Culley - YouTube
Adventrx Wraps Up $22.5M Registered Direct Offering
total taxane pharmaceutical market nearly $ 3 billion taxanes market ...
CORTICA Lands $75M, Adventrx Therapeutics Grabs $38M - dot.LA
Exhibit 99.1
Clear Financial Solutions Inc. – Clear Financial Solutions Inc.
77ADVENTRX Lead Product Candidates2008 - 2010 Goals
(FLOW CHART)
GRAPHIC
Click to edit Master title styleClick to edit Master text stylesSecond ...
PropThink Interview: ADVENTRX Pharmaceuticals - YouTube
ADVENTRX And Pierre Fabre Announce Manufacturing Agreement For ANX-188 ...
CoFactor vs LeucovorinCoFactor vs Leucovorin in5-FU-mediated Tumor Cell ...
(BAR CHART)
AMEX: ANXRefining therapies for life
6767
??Oncology Programs
Development Overview Product Development Steps ANX-530 ANX-514 ...
59Leucovorin/Isovorin MarketSources: IMS Health, Oncology, Inc.* all ...
California-San Diego-6725 Mesa Ridge Road Lease - Casey Family Trust ...
Rapid 65 Litre Front Opening Rucksack for Travelling and Hiking (Navy ...
TCA Portfolio - TCA Venture Group
Channel 80 Litre Front Opening Rucksack for Travelling and Hiking (Nav ...
